frisko6@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mr. Kirkov just got some new leads.
Thx, Rocky, I was just going to post that, Thats wonderful news for Elite, no more API probs. We'll see how the market reacts tommorrow, also, may make Elite attractive for a merger with one of the big boys,
Just a thought.
HUGE NEWS
What's this new 10ka all about
https://dd7pmep5szm19.cloudfront.net/2258/0001493152-23-026078.htm
your right Bubba, how do you short a stock like Elite, and why should you, it takes all day to go to 2 ticks and all day to go down 2 ticks,
like watching paint dry,
I'm sure they got better fish to fry.
This Naltrexone just won't go away.
https://stockhouse.com/news/press-releases/2023/07/25/vice-health-and-wellness-signs-letter-of-intent-to-acquire-naltrexone
Enter Mr. Kirkov, stage left
I knew the numbers were big,
in spring of 2023 many of the 45 million U.S. ADHD patients with prescriptions are experiencing intermittent delays in being able to access their medications.May 3, 2023
but not that big, Mr. Kirkov should have no problem selling during a shortage.
We'll have a good idea how he's doing in about 2 weeks, barring any delays.
Interesting, this Done site had 10k clicks in the past month/
https://www.donefirst.com/?utm_source=bing&utm_medium=cpc&utm_content=YM&msclkid=e7e2bb80f3e711a95b70df45b7125525
Read between the lines, I picked this out of an article
“Parents are calling us, saying the schools are asking (them) to pick up (their) child,’’ said Khan, who added she hasn’t experienced a shortage like this in her seven-year career.
From this article,
The kid was bouncing off the walls, they had to call the mom.
this is real
https://www.silive.com/news/2023/07/ongoing-adhd-medication-shortage-has-patients-doctors-on-staten-island-scrambling.html
OK, OK, I see nothing about Adderall in this new (mental health Parity)
https://edition.cnn.com/2023/07/25/politics/biden-mental-health-care-coverage/index.html
because they don't want to talk about it
thanks Rocky
Speculation alone should drive this stock
https://edition.cnn.com/2023/07/25/politics/biden-mental-health-care-coverage/index.html
new statement from Biden
https://news.yahoo.com/biden-administration-proposes-rules-push-091558089.html
if you can't read between the lines, your in the wrong stock
Another shortage report,
https://global.chinadaily.com.cn/a/202307/25/WS64bf27bda31035260b81852f.html
Elite sitting in the catbird seat
A million shares just went threw,
someone wants this thing BAD
Welcome back Couch Triip. hope you bring us some luck.
With this new accounting firm, they may not need a new CFO, if they do the books for Elite, they just need someone who can SPELL when doing SEC filings, lol
Number 1,
I have a new laptop and it is hot, very fast,
Mazars is HUGE, worldwide, they got an office in NJ. too, looks like an upgrade to me.
https://www.mazars.us/Offices/New-Jersey
and downtown manhattan
Bubba was right, it was a misprint, Mazars is out of NY,
From the OTC
https://www.otcmarkets.com/stock/ELTP/profile
That makes me feel better, what a shock. Mazars are top-notch/
A misspelling is easy with this one
Thats Mazars, check the spelling, Elite hired Mazers, looks like out of Boca Raton
https://www.mazercpa.com/
number 1
look at the prices for Walgreens DexAmp, it's huge
https://www.walgreens.com/images/adaptive/pdf/Walgreens-Plus_Drug-List_20180321.pdf
Mr. Kirkov must have gotten some big orders, their hiring more people
https://www.indeed.com/cmp/Elite-Pharmaceuticals,-Inc.-1/jobs
Lannett got a good write-up here.
https://www.drugs.com/answers/best-generic-brand-adderall-30mg-3460333.html
Elite makes a good product .
Bartells , Seattle, out of stock
https://www.bartelldrugs.com/pointy?query=generic+adderall&store-id=&clear=false
From a recent report.
The report notes that, overall, the percentage of enrollees who had prescriptions for stimulants and were in employer-sponsored health plans increased from 3.6% in 2016 to 4.1% in 2021.
this is important to Mr. Kirkov, were talking CO-PAY
https://www.marylandmatters.org/2023/07/11/shortage-of-drugs-to-treat-adhd-continues-as-studies-indicate-increase-in-prescriptions/
On yahoo fins. They finaly brought it up to 53 employees.
Thx, amother peice of the puzzle.
From a new article
For Dr. Clark’s pharmacy, he has been able to meet many of his customers’ needs by simply buying Adderall from wholesalers as soon as they become available.
Biloxi blues
https://www.msn.com/en-us/health/medical/adderall-shortage-continues-around-the-state/ar-AA1dBuxI
I just saw 4 cents, WOW
Were getting some Volume, it could break 4 cents today
And enter Mr. Kirkov, I expect him to put out a little Pub/Splash.
OKY DOAKY
Yep, you are absolutely correct.
In addition, the company submitted partial ANDA for pain management for review by FDA. The partial application contains the recently conducted insufflation study. Elite intends to provide the FDA with the remaining data in Q3 of 2023 to complete this filing. We disclosed a while back that we're actually continued working on a generic version of Oxycodone. And the last time we filed it, we had deficiencies and one of the deficiencies that everybody got is that an insufflation study was not conducted. It was cost prohibitive. That study alone is about $1.5 million, $2 million, and this is why we put the project on hold.
you just keep believing that.
Also, if you are the first to file , you get 180 start on everybody else, If I'm reading this right
Note: As outlined in the Proposed Criteria for First Generic Submissions for Purposes of ANDA, certain ANDAs are deemed “first generic” for the purposes of review prioritization. In this context, a first generic application is any received ANDA: (1) That is a first-to-file ANDA eligible for 180-day exclusivity, or for which there are no blocking patents or exclusivities; and (2) for which there is no previously-approved ANDA for the drug product.
from this link:
https://www.fda.gov/drugs/drug-and-biologic-approval-and-ind-activity-reports/first-generic-drug-approvals
Elite is a strong buy candidate
https://stockinvest.us/stock/ELTP
I dont see Elite on this list
https://pink.pharmaintelligence.informa.com/PS120021/Complete-Response-Letters
Thanks rdfdr1, not the most flattering report, but they leave out the intangibles, we all know what's happening with the transition, The next Q will give us a better perspective., looks like the middle of Aug. for the next report.
Not just another article, the last paragraph got to me, I know people in that condition.
https://www.nationalgeographic.com/premium/article/adderall-shortage-adult-adhd